Front. Oncol.

Frontiers in Oncology

Front. Oncol.

2234-943X

Frontiers Media S.A.

10.3389/fonc.2024.1516456

Oncology

Erratum

Erratum: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

Frontiers Production Office ^*

Frontiers Media SA, Lausanne, Switzerland

Approved by: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

05 11 2024

2024

1516456

24 10 2024 24 10 2024

2024

Frontiers Production Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

An erratum on Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers By Fattahi MR, Dehghani M, Paknahad S, Rahiminia S, Zareie D, Hoseini B, Oroomi TR, Motedayyen H and Arefnezhad R (2024). Front. Oncol. 14:1438297. doi: 10.3389/fonc.2024.1438297

nanomedicine nanoparticle urology cancer treatment clinical biosafety

section-in-acceptance

Genitourinary Oncology

Due to a production error, there was an error in affiliation 1. Instead of “School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran”, it should be “Student Research Committee, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran”. The publisher apologizes for this mistake.

The original version of this article has been updated.